etoposide has been researched along with Castleman Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, AR; Cipriano, P; Cristina, S; Toscano, M | 1 |
| Abbass, A; Eberhardt, S; Khalid, S; McCarthy, D; Toth, L | 1 |
| Hensel, M; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Siehl, J; Wyen, C | 1 |
| Doğu, MH; Eren, R; Gündoğan, C; Huq, GE; Kantarci, FE; Suyanı, E | 1 |
| Bower, M; Charles, P; Ibrahim, H; Kelleher, P; Naresh, KN; Nelson, M; Ngan, S; Stebbing, J | 1 |
| Oksenhendler, E | 1 |
| Bower, M; Gazzard, B; Lee, B; Merchant, S; Naresh, K; Nelson, M; Newsom-Davis, T; Stebbing, J | 1 |
| Achermann, Y; Fehr, J; Lederer, H; Stenner, F; Tinguely, M | 1 |
| Boulanger, E; Brière, J; Droz, D; Gaulard, P; Oksenhendler, E | 1 |
| Bradbeer, C; Collins, L; de Ruiter, A; Fowler, A; Kulasegaram, R; Whittaker, S | 1 |
| Cabral, L; Harrington, WJ; Scott, D | 1 |
1 review(s) available for etoposide and Castleman Disease
| Article | Year |
|---|---|
HIV-associated multicentric Castleman disease.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication | 2009 |
10 other study(ies) available for etoposide and Castleman Disease
| Article | Year |
|---|---|
Misdiagnosing multicentric Castleman's disease in an HIV-positive patient.
Topics: Castleman Disease; Diagnostic Errors; Etoposide; Fever; HIV Infections; Humans; Lymphadenopathy; Male; Middle Aged; Pancytopenia; Rituximab; Treatment Outcome | 2020 |
Ascites in the "TAFRO" Syndrome: Does the Squeeze Make the Juice?
Topics: Adult; Ascites; Castleman Disease; Diagnosis, Differential; Drug Therapy, Combination; Etoposide; Female; Humans; Predictive Value of Tests; Rituximab; Treatment Outcome | 2020 |
Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
Topics: Anti-HIV Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, AIDS-Related; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Radiotherapy, Adjuvant; Risk Assessment; Rituximab; Vincristine | 2014 |
A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination.
Topics: Antiviral Agents; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Ganciclovir; Herpesvirus 8, Human; Humans; Male; Middle Aged; Prednisolone; Rituximab; Valganciclovir; Vincristine | 2016 |
The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's disease.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Castleman Disease; Combined Modality Therapy; Cytokines; Drug Therapy, Combination; Etoposide; Herpesvirus 8, Human; HIV Infections; Humans; Immunologic Factors; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Rituximab; Splenectomy; Young Adult | 2008 |
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Castleman Disease; Comorbidity; Databases, Factual; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Middle Aged; Proportional Hazards Models; Rituximab; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.
Topics: Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Phytogenic; Antiviral Agents; Castleman Disease; Drug Therapy, Combination; Etoposide; Ganciclovir; HIV Infections; Humans; Immunologic Factors; Male; Middle Aged; Rituximab; Seizures, Febrile; Treatment Outcome; Valganciclovir | 2012 |
HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Castleman Disease; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Genital Neoplasms, Male; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Orchiectomy; Prednisone; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Spermatic Cord; Splenectomy; Tumor Virus Infections; Vincristine | 2003 |
Multicentric Castleman's disease in a patient with HIV.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Castleman Disease; Doxorubicin; Etoposide; Female; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Liposomes | 2006 |
Treatment of HIV-associated multicentric Castleman's disease with oral etoposide.
Topics: Administration, Oral; Adult; Anatomy, Cross-Sectional; Antineoplastic Agents, Phytogenic; Castleman Disease; DNA, Viral; Etoposide; Herpesvirus 8, Human; HIV Infections; Humans; Male; Middle Aged; Radiography; Tomography Scanners, X-Ray Computed | 2001 |